Dougall Norris is a postdoctoral researcher, cell biologist and microscopist in the laboratory of Associate Professor Michelle McDonald at the University of Sydney. He has a keen interest in the actions of bone modifying agents used in the clinic at a cellular level, particularly around Denosumab withdrawal, osteoclast biology (progenitors, cellular fates and regulation) and bone remodelling. Ultimately, he aims to improve current therapies for osteoporosis and cancer metastasis in the bone microenvironment.